Michael Lauseker

5.0k total citations
69 papers, 1.1k citations indexed

About

Michael Lauseker is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Lauseker has authored 69 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 28 papers in Genetics and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Lauseker's work include Chronic Myeloid Leukemia Treatments (26 papers), Acute Myeloid Leukemia Research (21 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Michael Lauseker is often cited by papers focused on Chronic Myeloid Leukemia Treatments (26 papers), Acute Myeloid Leukemia Research (21 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Michael Lauseker collaborates with scholars based in Germany, Netherlands and United States. Michael Lauseker's co-authors include Joerg Hasford, Rüdiger Hehlmann, Markus Pfirrmann, Susanne Saußele, Andreas Hochhaus, François‐André Allaert, C. Hamel-Desnos, M. Schadeck, Rainer Haas and Ulrich Germing and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Michael Lauseker

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Lauseker Germany 18 618 429 214 170 167 69 1.1k
Pravin Hissaria Australia 20 166 0.3× 169 0.4× 305 1.4× 81 0.5× 161 1.0× 92 1.6k
C. Larroche France 26 686 1.1× 284 0.7× 577 2.7× 305 1.8× 316 1.9× 68 2.3k
Toshihiko Imamura Japan 25 657 1.1× 152 0.4× 78 0.4× 338 2.0× 302 1.8× 139 1.9k
Andrew Daly Canada 24 950 1.5× 384 0.9× 48 0.2× 364 2.1× 146 0.9× 76 1.7k
Hossein C. Nousari United States 29 350 0.6× 812 1.9× 1.1k 5.1× 106 0.6× 142 0.9× 76 2.6k
Aiko Suminoe Japan 21 410 0.7× 110 0.3× 55 0.3× 290 1.7× 124 0.7× 47 1.3k
Shahram Kordasti United Kingdom 19 805 1.3× 292 0.7× 127 0.6× 258 1.5× 52 0.3× 76 1.6k
Hiroyuki Ohi Japan 23 314 0.5× 158 0.4× 152 0.7× 78 0.5× 208 1.2× 90 1.4k
S Fukuhara Japan 16 276 0.4× 162 0.4× 48 0.2× 187 1.1× 77 0.5× 34 1.0k
Marrie C.A. Bruin Netherlands 24 1.0k 1.6× 198 0.5× 41 0.2× 199 1.2× 95 0.6× 51 1.9k

Countries citing papers authored by Michael Lauseker

Since Specialization
Citations

This map shows the geographic impact of Michael Lauseker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lauseker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lauseker more than expected).

Fields of papers citing papers by Michael Lauseker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lauseker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lauseker. The network helps show where Michael Lauseker may publish in the future.

Co-authorship network of co-authors of Michael Lauseker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lauseker. A scholar is included among the top collaborators of Michael Lauseker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lauseker. Michael Lauseker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ernst, Philipp, Christine M. Lohse, Michael Lauseker, et al.. (2025). Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective. Leukemia. 40(1). 29–36.
2.
Bao, Han, et al.. (2024). Longitudinal evaluation of retinal neuroaxonal loss in epilepsy using optical coherence tomography. Epilepsia. 65(12). 3644–3654. 1 indexed citations
3.
Koenigsmann, Michael, et al.. (2023). Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR. Journal of Clinical Medicine. 12(20). 6569–6569. 2 indexed citations
4.
Silzle, Tobias, Sabine Blum, Kathrin Nachtkamp, et al.. (2023). The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score. Cancers. 15(14). 3572–3572. 2 indexed citations
5.
Bao, Han, Michael Lauseker, Georg Nübling, et al.. (2023). Association between retinal thickness and disease characteristics in adult epilepsy: A cross‐sectional OCT evaluation. Epilepsia Open. 9(1). 236–249. 6 indexed citations
6.
7.
8.
Rautenberg, Christina, Michael Lauseker, Jennifer Kaivers, et al.. (2021). Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS. European Journal Of Haematology. 107(2). 283–292. 15 indexed citations
9.
Kaufmann, Elisabeth, et al.. (2021). Acute effects of spaced cathodal transcranial direct current stimulation in drug resistant focal epilepsies. Clinical Neurophysiology. 132(7). 1444–1451. 14 indexed citations
10.
Lauseker, Michael, Jennifer Kaivers, Barbara Hildebrandt, et al.. (2021). Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients. Annals of Hematology. 100(10). 2575–2584. 4 indexed citations
11.
Schroeder, Thomas, Michael Lauseker, Christina Rautenberg, et al.. (2019). Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 25(8). 1550–1559. 43 indexed citations
12.
Piseddu, Ignazio, Gabriela M. Wiedemann, Michael Lauseker, et al.. (2018). CCL1 is a major regulatory T cell attracting factor in human breast cancer. BMC Cancer. 18(1). 1278–1278. 58 indexed citations
13.
Spöttl, Gerald, Julian Maurer, Michael Lauseker, et al.. (2018). The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance. Endocrine Related Cancer. 25(10). 893–908. 19 indexed citations
14.
Schoenberg, Markus Bo, Michael Thomas, Michael Lauseker, et al.. (2018). Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma. Surgical Oncology. 27(4). 663–673. 8 indexed citations
15.
Andrassy, Joachim, Sebastian Wolf, Michael Lauseker, et al.. (2017). Shipping of split-livers results in a higher retransplantation rate but does not affect overall patient's survival : an analysis from the Eurotransplant liver follow-up registry. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
16.
Nölting, Svenja, Helma Freitag, Katharina Detjen, et al.. (2017). The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models. PLoS ONE. 12(8). e0182852–e0182852. 28 indexed citations
17.
Andrassy, Joachim, Sebastian Wolf, Michael Lauseker, et al.. (2017). Higher retransplantation rate following extended right split‐liver transplantation: An analysis from the eurotransplant liver follow‐up registry. Liver Transplantation. 24(1). 26–34. 18 indexed citations
18.
Lauseker, Michael, Benjamin Hanfstein, Claudia Haferlach, et al.. (2014). Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase. Journal of Cancer Research and Clinical Oncology. 140(11). 1965–1969. 19 indexed citations
19.
Horstmann, S., Timolaos Rizos, Michael Lauseker, et al.. (2013). Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study. Journal of Neurology. 260(8). 2046–2051. 29 indexed citations
20.
Neukirchen, Judith, Michael Lauseker, Sabine Blum, et al.. (2013). Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study. Leukemia Research. 38(1). 57–64. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pravin Hissaria Breakdown of academic impact, for papers by C. Larroche Breakdown of academic impact, for papers by Toshihiko Imamura Breakdown of academic impact, for papers by Andrew Daly Breakdown of academic impact, for papers by Hossein C. Nousari Breakdown of academic impact, for papers by Aiko Suminoe Breakdown of academic impact, for papers by Shahram Kordasti Breakdown of academic impact, for papers by Hiroyuki Ohi Breakdown of academic impact, for papers by S Fukuhara Breakdown of academic impact, for papers by Marrie C.A. Bruin
Rankless by CCL
2026